https://w8md.com/w/index.php?action=history&feed=atom&title=Template%3AGLP-1 2026-08-30T23:30:36Z Revision history for this page on the wiki MediaWiki 1.39.1 https://w8md.com/w/index.php?title=Template:GLP-1&diff=5407&oldid=prev 2026-06-23T19:49:17Z

<p>Created page with &quot;&lt;includeonly&gt;{{Navbox | name = GLP-1 | title = <a href="/wiki/GLP-1_receptor_agonist" class="mw-redirect" title="GLP-1 receptor agonist">GLP-1 receptor agonists</a>, <a href="/wiki/Incretin_therapy" title="Incretin therapy">incretin therapy</a>, and weight loss medications | state = {{{state|collapsed}}} | bodyclass = hlist | group1 = Overview | list1 = * <a href="/wiki/GLP-1" class="mw-redirect" title="GLP-1">GLP-1</a> * <a href="/wiki/Glucagon-like_peptide-1" class="mw-redirect" title="Glucagon-like peptide-1">Glucagon-like peptide-1</a> * <a href="/wiki/GLP-1_receptor_agonist" class="mw-redirect" title="GLP-1 receptor agonist">GLP-1 receptor agonist</a> * <a href="/wiki/Incretin_therapy" title="Incretin therapy">Incretin therapy</a> * <a href="/w/index.php?title=Incretin_hormone&amp;action=edit&amp;redlink=1" class="new" title="Incretin hormone (page does not exist)">Incretin hormone</a> * <a href="/w/index.php?title=GIP&amp;action=edit&amp;redlink=1" class="new" title="GIP (page does not exist)">GIP</a> * <a href="/w/index.php?title=Glucose-dependent_insulinotropic_polypeptide&amp;action=edit&amp;redlink=1" class="new" title="Glucose-dependent insulinotropic polypeptide (page does not exist)">Glucose-dependent insulinotropic polypeptide</a> * <a href="/wiki/Glucagon" title="Glucagon">Glucagon</a> * <a href="/w/index.php?title=Amylin&amp;action=edit&amp;redlink=1" class="new" title="Amylin (page does not exist)">Amylin</a> * <a href="/w/index.php?title=Appetite_regulation&amp;action=edit&amp;redlink=1" class="new" title="Appetite regulation (page does not exist)">Appetite regulation</a> * <a href="/w/index.php?title=Satiety&amp;action=edit&amp;redlink=1" class="new" title="Satiety (page does not exist)">Satiety</a> * Gastric emptyin...&quot;</p> <p><b>New page</b></p><div>&lt;includeonly&gt;{{Navbox<br /> | name = GLP-1<br /> | title = [[GLP-1 receptor agonist]]s, [[incretin therapy]], and weight loss medications<br /> | state = {{{state|collapsed}}}<br /> | bodyclass = hlist<br /> <br /> | group1 = Overview<br /> | list1 =<br /> * [[GLP-1]]<br /> * [[Glucagon-like peptide-1]]<br /> * [[GLP-1 receptor agonist]]<br /> * [[Incretin therapy]]<br /> * [[Incretin hormone]]<br /> * [[GIP]]<br /> * [[Glucose-dependent insulinotropic polypeptide]]<br /> * [[Glucagon]]<br /> * [[Amylin]]<br /> * [[Appetite regulation]]<br /> * [[Satiety]]<br /> * [[Gastric emptying]]<br /> * [[Insulin secretion]]<br /> * [[Glucagon suppression]]<br /> * [[Medical weight loss]]<br /> * [[Obesity medicine]]<br /> <br /> | group2 = FDA-approved weight loss medications<br /> | list2 =<br /> * [[Semaglutide]]<br /> * [[Wegovy]]<br /> * [[Liraglutide]]<br /> * [[Saxenda]]<br /> * [[Tirzepatide]]<br /> * [[Zepbound]]<br /> * [[GLP-1 weight loss]]<br /> * [[Weight loss injection]]<br /> * [[Anti-obesity medication]]<br /> * [[Prescription weight loss medication]]<br /> * [[Chronic weight management]]<br /> * [[Long-term weight maintenance]]<br /> <br /> | group3 = Diabetes medications also used in weight care<br /> | list3 =<br /> * [[Ozempic]]<br /> * [[Mounjaro]]<br /> * [[Victoza]]<br /> * [[Rybelsus]]<br /> * [[Dulaglutide]]<br /> * [[Trulicity]]<br /> * [[Exenatide]]<br /> * [[Byetta]]<br /> * [[Bydureon]]<br /> * [[Lixisenatide]]<br /> * [[Adlyxin]]<br /> * [[Diabetes medication]]<br /> * [[Type 2 diabetes]]<br /> * [[Insulin resistance]]<br /> <br /> | group4 = Semaglutide topics<br /> | list4 =<br /> * [[Semaglutide]]<br /> * [[Semaglutide weight loss]]<br /> * [[Wegovy]]<br /> * [[Ozempic]]<br /> * [[Rybelsus]]<br /> * [[Wegovy for weight loss]]<br /> * [[Ozempic for weight loss]]<br /> * [[Semaglutide injection]]<br /> * [[Semaglutide side effects]]<br /> * [[Semaglutide dose escalation]]<br /> * [[Semaglutide and appetite]]<br /> * [[Semaglutide and cardiovascular risk]]<br /> * [[Semaglutide maintenance therapy]]<br /> <br /> | group5 = Tirzepatide topics<br /> | list5 =<br /> * [[Tirzepatide]]<br /> * [[Tirzepatide weight loss]]<br /> * [[Zepbound]]<br /> * [[Mounjaro]]<br /> * [[Zepbound for weight loss]]<br /> * [[Mounjaro for weight loss]]<br /> * [[Tirzepatide injection]]<br /> * [[Tirzepatide side effects]]<br /> * [[Tirzepatide dose escalation]]<br /> * [[Tirzepatide and appetite]]<br /> * [[Tirzepatide and sleep apnea]]<br /> * [[Zepbound for sleep apnea]]<br /> * [[Dual GIP and GLP-1 receptor agonist]]<br /> <br /> | group6 = Liraglutide topics<br /> | list6 =<br /> * [[Liraglutide]]<br /> * [[Saxenda]]<br /> * [[Victoza]]<br /> * [[Liraglutide weight loss]]<br /> * [[Daily GLP-1 injection]]<br /> * [[Liraglutide side effects]]<br /> * [[Liraglutide maintenance therapy]]<br /> <br /> | group7 = Emerging and investigational incretin therapies<br /> | list7 =<br /> * [[Retatrutide]]<br /> * [[Ritatrutide|Retatrutide]]<br /> * [[Triple agonist]]<br /> * [[Triple hormone receptor agonist]]<br /> * [[GIP/GLP-1/glucagon receptor agonist]]<br /> * [[CagriSema]]<br /> * [[Cagrilintide]]<br /> * [[Cagrilintide and semaglutide]]<br /> * [[Amycretin]]<br /> * [[Orforglipron]]<br /> * [[Danuglipron]]<br /> * [[Survodutide]]<br /> * [[Mazdutide]]<br /> * [[Pemvidutide]]<br /> * [[VK2735]]<br /> * [[MariTide]]<br /> * [[AMG 133]]<br /> * [[Ecnoglutide]]<br /> * [[Efinopegdutide]]<br /> * [[Investigational weight loss medication]]<br /> * [[Obesity drug pipeline]]<br /> <br /> | group8 = Emerging peptide and metabolic therapies<br /> | list8 =<br /> * [[Peptide weight loss medication]]<br /> * [[Amylin analog]]<br /> * [[Amylin receptor agonist]]<br /> * [[Cagrilintide]]<br /> * [[Pramlintide]]<br /> * [[GLP-1 and amylin combination]]<br /> * [[GLP-1/glucagon receptor agonist]]<br /> * [[GIP receptor agonist]]<br /> * [[GIP receptor antagonist]]<br /> * [[Glucagon receptor agonist]]<br /> * [[Melanocortin receptor agonist]]<br /> * [[Setmelanotide]]<br /> * [[Bimagrumab]]<br /> * [[Myostatin inhibitor]]<br /> * [[Activin receptor inhibitor]]<br /> * [[MASH weight loss medication]]<br /> * [[Metabolic peptide therapy]]<br /> <br /> | group9 = Oral GLP-1 and non-injectable options<br /> | list9 =<br /> * [[Oral semaglutide]]<br /> * [[Rybelsus]]<br /> * [[Orforglipron]]<br /> * [[Danuglipron]]<br /> * [[Oral GLP-1]]<br /> * [[Oral incretin therapy]]<br /> * [[Non-peptide GLP-1 receptor agonist]]<br /> * [[Weight loss pill]]<br /> * [[Oral anti-obesity medication]]<br /> * [[GLP-1 adherence]]<br /> * [[GLP-1 convenience]]<br /> <br /> | group10 = Mechanisms and metabolic effects<br /> | list10 =<br /> * [[Appetite suppression]]<br /> * [[Satiety]]<br /> * [[Food cravings]]<br /> * [[Gastric emptying]]<br /> * [[Insulin secretion]]<br /> * [[Glucagon]]<br /> * [[Blood glucose control]]<br /> * [[Hemoglobin A1c]]<br /> * [[Insulin resistance]]<br /> * [[Energy intake]]<br /> * [[Calorie restriction]]<br /> * [[Weight loss]]<br /> * [[Weight maintenance]]<br /> * [[Metabolic health]]<br /> * [[Cardiovascular risk]]<br /> * [[Fatty liver disease]]<br /> * [[Obstructive sleep apnea]]<br /> <br /> | group11 = Indications and related conditions<br /> | list11 =<br /> * [[Obesity]]<br /> * [[Overweight]]<br /> * [[Chronic weight management]]<br /> * [[Type 2 diabetes]]<br /> * [[Prediabetes]]<br /> * [[Insulin resistance]]<br /> * [[Metabolic syndrome]]<br /> * [[Fatty liver disease]]<br /> * [[Metabolic dysfunction-associated steatotic liver disease]]<br /> * [[Obstructive sleep apnea]]<br /> * [[Sleep apnea]]<br /> * [[Hypertension]]<br /> * [[Dyslipidemia]]<br /> * [[Polycystic ovary syndrome]]<br /> * [[Menopause weight gain]]<br /> * [[Abdominal obesity]]<br /> * [[Cardiovascular disease]]<br /> <br /> | group12 = Side effects and safety<br /> | list12 =<br /> * [[GLP-1 side effects]]<br /> * [[Nausea]]<br /> * [[Vomiting]]<br /> * [[Diarrhea]]<br /> * [[Constipation]]<br /> * [[Abdominal pain]]<br /> * [[Gastroparesis]]<br /> * [[Pancreatitis]]<br /> * [[Gallbladder disease]]<br /> * [[Cholelithiasis]]<br /> * [[Hypoglycemia]]<br /> * [[Dehydration]]<br /> * [[Kidney injury]]<br /> * [[Muscle loss]]<br /> * [[Malnutrition]]<br /> * [[Thyroid C-cell tumor warning]]<br /> * [[Medication contraindication]]<br /> * [[Drug interaction]]<br /> <br /> | group13 = Treatment planning<br /> | list13 =<br /> * [[GLP-1 consultation]]<br /> * [[GLP-1 eligibility]]<br /> * [[GLP-1 prior authorization]]<br /> * [[GLP-1 dose escalation]]<br /> * [[GLP-1 follow-up]]<br /> * [[GLP-1 maintenance therapy]]<br /> * [[GLP-1 weight regain]]<br /> * [[Stopping GLP-1 medications]]<br /> * [[Restarting GLP-1 medications]]<br /> * [[Protein intake]]<br /> * [[Resistance training]]<br /> * [[Meal replacements]]<br /> * [[Nutrition counseling]]<br /> * [[Long-term weight maintenance]]<br /> * [[Weight loss plateau]]<br /> * [[Weight regain prevention]]<br /> <br /> | group14 = Compounded and unapproved GLP-1 issues<br /> | list14 =<br /> * [[Compounded semaglutide]]<br /> * [[Compounded tirzepatide]]<br /> * [[Unapproved GLP-1 drugs]]<br /> * [[GLP-1 safety]]<br /> * [[FDA-approved medication]]<br /> * [[Drug compounding]]<br /> * [[Medication quality]]<br /> * [[Medication safety]]<br /> * [[Counterfeit medication]]<br /> * [[Online weight loss medication]]<br /> * [[Telemedicine weight loss]]<br /> * [[Prescription safety]]<br /> <br /> | group15 = W8MD GLP-1 resources<br /> | list15 =<br /> * [[W8MD Weight Loss, Sleep and MedSpa]]<br /> * [[W8MD Weight Loss]]<br /> * [[Medical weight loss]]<br /> * [[GLP-1 weight loss at W8MD]]<br /> * [[Semaglutide at W8MD]]<br /> * [[Tirzepatide at W8MD]]<br /> * [[Wegovy doctor]]<br /> * [[Zepbound doctor]]<br /> * [[Ozempic weight loss]]<br /> * [[Mounjaro weight loss]]<br /> * [[GLP-1 clinic Brooklyn]]<br /> * [[GLP-1 clinic NYC]]<br /> * [[GLP-1 clinic Philadelphia]]<br /> * [[Weight loss doctor Brooklyn]]<br /> * [[Weight loss doctor Philadelphia]]<br /> * [[Sleep apnea and GLP-1]]<br /> * [[Zepbound for sleep apnea]]<br /> <br /> | group16 = Locations<br /> | list16 =<br /> * [[W8MD Brooklyn]]<br /> * [[W8MD Brooklyn NY]]<br /> * [[W8MD New York City]]<br /> * [[W8MD NYC]]<br /> * [[W8MD Philadelphia]]<br /> * [[W8MD Philadelphia PA]]<br /> * [[Brooklyn weight loss]]<br /> * [[NYC weight loss]]<br /> * [[Philadelphia weight loss]]<br /> * [[Brooklyn GLP-1]]<br /> * [[NYC GLP-1]]<br /> * [[Philadelphia GLP-1]]<br /> }}&lt;/includeonly&gt;&lt;noinclude&gt;<br /> {{Documentation}}<br /> <br /> == Usage ==<br /> This template is a navigation box for articles related to [[GLP-1 receptor agonist]]s, [[incretin therapy]], [[semaglutide]], [[tirzepatide]], [[liraglutide]], [[medical weight loss]], [[obesity medicine]], and emerging investigational peptide or incretin-based therapies such as [[Retatrutide]], [[CagriSema]], [[Amycretin]], [[Survodutide]], [[Mazdutide]], [[Pemvidutide]], [[VK2735]], and [[MariTide]].<br /> <br /> &lt;pre&gt;<br /> {{GLP-1}}<br /> &lt;/pre&gt;<br /> <br /> Collapsed state:<br /> <br /> &lt;pre&gt;<br /> {{GLP-1|state=collapsed}}<br /> &lt;/pre&gt;<br /> <br /> Expanded state:<br /> <br /> &lt;pre&gt;<br /> {{GLP-1|state=expanded}}<br /> &lt;/pre&gt;<br /> <br /> == Notes ==<br /> * [[Retatrutide]] is sometimes misspelled as &quot;Ritatrutide&quot;; this template includes both link forms for search and navigation convenience.<br /> * Emerging and investigational medications should be described clearly as investigational unless they receive regulatory approval.<br /> * Pages about compounded or unapproved GLP-1 drugs should include appropriate safety language and should not imply FDA approval unless applicable.<br /> <br /> == See also ==<br /> * [[Template:W8MD]]<br /> * [[Template:Medical weight loss]]<br /> * [[Template:Obesity]]<br /> * [[GLP-1 receptor agonist]]<br /> * [[Medical weight loss]]<br /> * [[Anti-obesity medication]]<br /> * [[Obesity]]<br /> * [[Weight maintenance]]<br /> <br /> [[Category:GLP-1 templates]]<br /> [[Category:Medical weight loss templates]]<br /> [[Category:Obesity templates]]<br /> [[Category:W8MD templates]]<br /> [[Category:Navigation templates]]<br /> &lt;/noinclude&gt;</div>

Prab